心脏外科术后INTELLiVENT自适应支持通气(POSITiVE)II研究:一项随机临床试验方案
POSITiVE II是一项国际多中心、两组、随机、优效性临床试验,计划纳入328例择期心脏手术后预期术后ICU通气超过2小时的成人患者,比较INTELLiVENT-ASV自动通气与常规非自动通气的通气质量,主要终点为术后前2小时通气参数处于预设最佳、可接受和关键(损伤性)范围的时间占比。
要点
- POSITiVE II为国际多中心随机优效性试验,计划随机328例心脏术后患者。
- 主要终点为术后前2小时通气参数处于预设最佳、可接受和关键范围的时间占比。
- 次要终点包括ICU团队工作量、术后通气时长和ICU住院时间。
核心结论
- POSITiVE II旨在确证心脏术后INTELLiVENT-ASV优于非自动常规通气,并次要确定该闭环通气模式是否减少ICU团队工作量。
研究设计与样本
- 国际多中心、两组、随机临床优效性试验,计划随机328例年龄>18岁、择期心脏手术、预期术后ICU通气超过2小时的患者。
- 患者随机接受INTELLiVENT-ASV自动通气或常规非自动通气模式通气。
主要发现
- 主要终点为通气质量,定义为术后前2小时通气时间中处于预设最佳、可接受和关键(损伤性)通气参数范围的比例。
- 主要次要终点之一为ICU团队工作量,通过呼吸机软件采集报警相关手动设置来捕获。
- 以患者为中心的终点包括术后通气时长和ICU住院时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One single-center randomized clinical trial showed that INTELLiVENT-adaptive support ventilation (ASV) is superior to conventional ventilation with respect to the quality of ventilation in post-cardiac surgery patients. Other studies showed that this automated ventilation mode reduces the number of manual interventions at the ventilator in various types of critically ill patients. In this multicenter study in patients post-cardiac surgery, we test the hypothesis that INTELLiVENT-ASV is superior to conventional ventilation with respect to the quality of ventilation. METHODS: "POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II)" is an international, multicenter, two-group randomized clinical superiority trial. In total, 328 cardiac surgery patients will be randomized. Investigators screen patients aged > 18 years of age, scheduled for elective cardiac surgery, and expected to receive postoperative ventilation in the ICU for longer than 2 h. Patients either receive automated ventilation by means of INTELLiVENT-ASV or ventilation that is not automated by means of a conventional ventilation mode. The primary endpoint is quality of ventilation, defined as the proportion of postoperative ventilation time characterized by exposure to predefined optimal, acceptable, and critical (injurious) ventilatory parameters in the first two postoperative hours. One major secondary endpoint is ICU team staff workload, captured by the ventilator software collecting manual settings on alarms. Patient-centered endpoints include duration of postoperative ventilation and length of stay in ICU. DISCUSSION: POSITiVE II is the first international, multicenter, randomized clinical trial designed to confirm that POStoperative INTELLiVENT-ASV is superior to non-automated conventional ventilation and secondary to determine if this closed-loop ventilation mode reduces ICU team staff workload. The results of POSITiVE II will support intensive care teams in their choices regarding the use of automated ventilation in postoperative care of uncomplicated cardiac surgery patients. TRIAL REGISTRATION: Clinicaltrials.gov NCT06178510 . Registered on December 4, 2023.
引用
- Bernardi MH, Bettex D, Buiteman-Kruizinga LA, et al. POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients (POSITiVE) II-study protocol of a randomized clinical trial. Trials. 2024. PMID: 38961468. doi:10.1186/s13063-024-08296-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。